Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Archimedes, Inc. Expands Use of Big Data in Healthcare Modeling and Analytics

Published: Thursday, March 28, 2013
Last Updated: Thursday, March 28, 2013
Bookmark and Share
New solutions incorporate additional real-world data sources to extend and customize modeling and analytic offerings.

Archimedes, Inc., a healthcare modeling and analytics company, announced today that it is substantially expanding its modeling and analytics solutions. New product offerings and disease models will enable users to more quickly and easily access and analyze information related to their complex questions. Archimedes customers will be able to further enhance their modeling and analytic projects by integrating their own electronic health records (EHR), claims, clinical trial, and pharmacokinetic/pharmacodynamic (PK/PD) simulation outcomes data with data from Archimedes simulations and proprietary algorithms. This integrated data will be accessed and analyzed through novel interfaces that offer near-instant results.

For more than ten years, the company has been working to proactively identify new opportunities where big data can play a role in the healthcare continuum – from research and development to the point of patient care. The advancements, which will become available throughout 2013, represent Archimedes’ continued commitment to its vision of revolutionizing medicine worldwide through mathematics.

“At Archimedes, we are dedicated to harnessing the power of big, real-world data by developing healthcare modeling and analytics tools,” said David Eddy, M.D., Ph.D. founder of Archimedes and pioneer in the area of evidenced-based medicine. “We are continually developing tools that can help researchers, life-science organizations, government agencies, payers, and providers get the most from the available data. Archimedes is excited to announce that, starting today, we will be providing free access through our website to new, easy-to-use tools for addressing some of healthcare’s most complex questions.”

Since inception, Archimedes has been striving to improve efficiencies in the healthcare system by developing quantitative methods for analyzing healthcare decisions at the individual and population levels. The tools, including the new ARCHeS Population Explorer, take modeling and analytics a step further by delivering big data to the fingertips of users, making it easier and faster to gather, enhance, and analyze multiple datasets. In the current era of accountability in medical decision making, it is critical that actionable data analytics tools are made available to the people who need them most.

The Archimedes Model is the most advanced mathematical modeling tool available to answer complex questions regarding health and healthcare. It is a clinically realistic, trial-validated, mathematical model of human physiology, diseases, interventions, and healthcare systems. By using advanced methods of mathematics, computing, and data systems, the Model enables researchers and decision makers to make better informed decisions. Archimedes continually validates the Model by comparing the results of simulated trials to the results of multinational clinical trials and cohort studies. The Model is the foundation behind the various solutions offered by Archimedes – including ARCHeS, the population-focused research platform, and IndiGO, the clinical-decision support tool for use by physicians and patients at the point-of-care.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Cancer Cells Kill Off Healthy Neighbours
Cancer cells create space to grow by killing off surrounding healthy cells, according to UK researchers working with fruit flies.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Bile Acid Supports Production of Blood Stem Cells
A research group at Lund University has been able to show that bile acid is transferred from the mother to the foetus via the placenta to enable the foetus to produce blood stem cells.
Chemical Used to Replace BPA is Potentially Toxic
This study is the first to examine the effects of BPA and BPS on brain cells and genes that control the growth and function of organs involved in reproduction.
A Better Model for Parkinson's
Scientists at EPFL solve a longstanding problem with modeling Parkinson’s disease in animals. Using newfound insights, they improve both cell and animal models for the disease, which can propel research and drug development.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Toxicity Testing With Cultured Liver Cells
Microreactor replaces animal testing.
Neural Networks Adapt to the Presence of a Toxic HIV Protein
HIV-associated neurocognitive disorders (HAND) afflict approximately half of HIV infected patients.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!